Profile

Mediphage is a Toronto-based biotech that developed a scalable E.coli-based manufacturing process to produce its proprietary and backbone-free mini-string DNA (msDNA), which is a linear, high fidelity, covalently closed double-stranded DNA vector. msDNA can be used as a starting material for rAAV (recombinant adeno-associated virus), lentivirus, and mRNA production and as a drug substance in applications like non-viral gene addition, gene editing, and DNA vaccines. The demand for high-fidelity backbone-free DNA is present as currently, Mediphage has several collaborations with various large pharma, biotech companies and prestigious CDMOs (contract development and manufacturing organization).

Mediphage Bioceuticals Inc. logo

Website

mediphage.ca

Contact


Event details

Date: November 4 - 6, 2024

Event contact

Rita Patlan
Area Director
Europe: Aerospace and Defence, Environmental Technologies and Infrastructure

Participants

12 in total